BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30583070)

  • 1. Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway.
    Xiao W; Xu Z; Chang S; Li B; Yu D; Wu H; Xie Y; Wang Y; Xie B; Sun X; Kong Y; Lan X; Bu W; Chen G; Gao L; Wu X; Shi J; Zhu W
    Cancer Lett; 2019 Mar; 444():45-59. PubMed ID: 30583070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer.
    Shi X; Li H; Shi A; Yao H; Ke K; Dong C; Zhu Y; Qin Y; Ding Y; He YH; Liu X; Li L; Lei L; Hai Q; Chen W; Leung KS; Wong MH; Kung HF; Lin MC
    Oncol Rep; 2018 Sep; 40(3):1592-1600. PubMed ID: 29956794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth.
    Yasui H; Hideshima T; Ikeda H; Jin J; Ocio EM; Kiziltepe T; Okawa Y; Vallet S; Podar K; Ishitsuka K; Richardson PG; Pargellis C; Moss N; Raje N; Anderson KC
    Br J Haematol; 2007 Feb; 136(3):414-23. PubMed ID: 17173546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effects of rafoxanide in diffuse large B cell lymphoma via the PTEN/PI3K/Akt and JNK/c-Jun pathways.
    He W; Xu Z; Song D; Zhang H; Li B; Gao L; Zhang Y; Feng Q; Yu D; Hu L; Chen G; Tao Y; Wu X; Shi J; Zhu W
    Life Sci; 2020 Feb; 243():117249. PubMed ID: 31926247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rafoxanide promotes apoptosis and autophagy of gastric cancer cells by suppressing PI3K /Akt/mTOR pathway.
    Liu JZ; Hu YL; Feng Y; Guo YB; Liu YF; Yang JL; Mao QS; Xue WJ
    Exp Cell Res; 2019 Dec; 385(2):111691. PubMed ID: 31678170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo.
    Navas TA; Nguyen AN; Hideshima T; Reddy M; Ma JY; Haghnazari E; Henson M; Stebbins EG; Kerr I; O'Young G; Kapoun AM; Chakravarty S; Mavunkel B; Perumattam J; Luedtke G; Dugar S; Medicherla S; Protter AA; Schreiner GF; Anderson KC; Higgins LS
    Leukemia; 2006 Jun; 20(6):1017-27. PubMed ID: 16617327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced anticancer efficacy of snake venom combined with silica nanoparticles in a murine model of human multiple myeloma: molecular targets for cell cycle arrest and apoptosis induction.
    Al-Sadoon MK; Rabah DM; Badr G
    Cell Immunol; 2013; 284(1-2):129-38. PubMed ID: 23973876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
    Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G
    Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
    Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
    Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evodiamine induces apoptosis and inhibits metastasis in MDA‑MB-231 human breast cancer cells in vitro and in vivo.
    Du J; Wang XF; Zhou QM; Zhang TL; Lu YY; Zhang H; Su SB
    Oncol Rep; 2013 Aug; 30(2):685-94. PubMed ID: 23708383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe.
    Hu L; Li B; Chen G; Song D; Xu Z; Gao L; Xi M; Zhou J; Li L; Zhang H; Feng Q; Wang Y; Lu K; Lu Y; Bu W; Wang H; Wu X; Zhu W; Shi J
    J Exp Clin Cancer Res; 2020 Jun; 39(1):105. PubMed ID: 32517809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells.
    Wen J; Cheng HY; Feng Y; Rice L; Liu S; Mo A; Huang J; Zu Y; Ballon DJ; Chang CC
    Br J Haematol; 2008 Jan; 140(2):169-80. PubMed ID: 18173754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of endoplasmic reticulum stress and inhibition of colon carcinogenesis by the anti-helmintic drug rafoxanide.
    Laudisi F; Di Grazia A; De Simone V; Cherubini F; Colantoni A; Ortenzi A; Franzè E; Dinallo V; Di Fusco D; Monteleone I; Fearon ER; Monteleone G; Stolfi C
    Cancer Lett; 2019 Oct; 462():1-11. PubMed ID: 31351087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calmodulin antagonists induce cell cycle arrest and apoptosis in vitro and inhibit tumor growth in vivo in human multiple myeloma.
    Yokokura S; Yurimoto S; Matsuoka A; Imataki O; Dobashi H; Bandoh S; Matsunaga T
    BMC Cancer; 2014 Nov; 14():882. PubMed ID: 25424011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells.
    Chen G; Xu Z; Chang G; Hou J; Hu L; Zhang Y; Yu D; Li B; Chang S; Xie Y; Zhang Y; Wei R; Wu H; Xiao W; Sun X; Tao Y; Gao L; Dai B; Shi J; Zhu W
    Oncol Rep; 2017 Jul; 38(1):488-496. PubMed ID: 28560392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Mangostin induces mitochondrial dependent apoptosis in human hepatoma SK-Hep-1 cells through inhibition of p38 MAPK pathway.
    Hsieh SC; Huang MH; Cheng CW; Hung JH; Yang SF; Hsieh YH
    Apoptosis; 2013 Dec; 18(12):1548-60. PubMed ID: 23912717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells.
    Das DS; Das A; Ray A; Song Y; Samur MK; Munshi NC; Chauhan D; Anderson KC
    Clin Cancer Res; 2017 Aug; 23(15):4280-4289. PubMed ID: 28270494
    [No Abstract]   [Full Text] [Related]  

  • 18. Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways.
    Kobayashi T; Kuroda J; Ashihara E; Oomizu S; Terui Y; Taniyama A; Adachi S; Takagi T; Yamamoto M; Sasaki N; Horiike S; Hatake K; Yamauchi A; Hirashima M; Taniwaki M
    Leukemia; 2010 Apr; 24(4):843-50. PubMed ID: 20200560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DCZ0801, a novel compound, induces cell apoptosis and cell cycle arrest via MAPK pathway in multiple myeloma.
    Zhang T; Li B; Feng Q; Xu Z; Huang C; Wu H; Chen Z; Hu L; Gao L; Liu P; Yang G; Zhang H; Lu K; Li T; Tao Y; Wu X; Shi J; Zhu W
    Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):517-523. PubMed ID: 30947332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-proliferation and anti-metastasis effect of barbaloin in non-small cell lung cancer via inactivating p38MAPK/Cdc25B/Hsp27 pathway.
    Zhang Z; Rui W; Wang ZC; Liu DX; Du L
    Oncol Rep; 2017 Aug; 38(2):1172-1180. PubMed ID: 28656293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.